Linda Llewelyn Sells 2,005 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) Stock

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 2,005 shares of the stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $6.11, for a total transaction of $12,250.55. Following the completion of the sale, the insider now owns 126,226 shares of the company’s stock, valued at approximately $771,240.86. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Health Catalyst Stock Performance

NASDAQ:HCAT opened at $5.70 on Friday. The firm has a market capitalization of $333.50 million, a PE ratio of -2.71 and a beta of 1.29. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. Health Catalyst, Inc. has a 1 year low of $5.51 and a 1 year high of $14.37. The firm’s fifty day simple moving average is $7.88 and its 200 day simple moving average is $8.44.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings results on Thursday, February 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.06. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. The company had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. On average, sell-side analysts anticipate that Health Catalyst, Inc. will post -0.47 EPS for the current year.

Institutional Trading of Health Catalyst

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Nepsis Inc. boosted its position in shares of Health Catalyst by 20.5% in the fourth quarter. Nepsis Inc. now owns 1,091,932 shares of the company’s stock valued at $10,111,000 after acquiring an additional 186,128 shares during the period. Bank of New York Mellon Corp grew its position in Health Catalyst by 124.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company’s stock worth $8,652,000 after purchasing an additional 473,323 shares during the last quarter. Vanguard Group Inc. grew its position in Health Catalyst by 1.2% in the 3rd quarter. Vanguard Group Inc. now owns 6,441,707 shares of the company’s stock worth $65,190,000 after purchasing an additional 78,823 shares during the last quarter. MQS Management LLC bought a new position in shares of Health Catalyst during the 3rd quarter worth about $116,000. Finally, American Century Companies Inc. raised its position in shares of Health Catalyst by 10.4% during the third quarter. American Century Companies Inc. now owns 657,552 shares of the company’s stock valued at $6,654,000 after buying an additional 62,010 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HCAT shares. Piper Sandler reiterated an “overweight” rating and set a $15.00 price objective (down from $17.00) on shares of Health Catalyst in a report on Friday, February 23rd. KeyCorp reiterated a “sector weight” rating on shares of Health Catalyst in a report on Wednesday, April 10th. Evercore ISI dropped their price target on shares of Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. Guggenheim raised shares of Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price objective for the company in a research note on Friday, January 26th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $16.00 target price on shares of Health Catalyst in a research report on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Health Catalyst has an average rating of “Moderate Buy” and an average price target of $12.10.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.